AUG 12, 2026 · JOURNAL ARTICLE
Hypothesis-driven salvage therapy with corticosteroids, tofacitinib, and nintedanib for progressive radiation pneumonitis with possible immune-mediated contribution: a case report
Frontiers in Immunology
A single case report with clinical improvement and biomarker response, but no control group, no prospective design, and no evidence of safety or efficacy beyond one patient.
Reported
Patient age65 years
Primary diagnosisesophageal cancer
Treatment-related adverse events…none clinically evident